U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
145081145081Evaluating the Efficacy Vardenafil 10 mg vs Tadalafil 10 mg in in Subjects With Erectile Dysfunction (ED)CompletedNo Results AvailableErectile DysfunctionDrug: Levitra (Vardenafil, BAY38-9456)|Drug: Tadalafilhttps://ClinicalTrials.gov/show/NCT00663130
145082145082The Effects of Naltrexone on Active Crohn's DiseaseCompletedHas ResultsInflammation|Crohn's DiseaseDrug: Naltrexone-HCl|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00663117
145083145083Effect of Exercise and Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early MenopauseTerminatedNo Results AvailableBone Diseases|Metabolic Syndrome X|Coronary DiseaseBehavioral: exercise|Behavioral: exercise + cimicifuga racemosa|Behavioral: wellness control, placebohttps://ClinicalTrials.gov/show/NCT00663104
145084145084A Prospective, Randomized, Double-Blind Controlled Study of WPP-201 for the Safety and Efficacy of Treatment of Venous Leg UlcersCompletedNo Results AvailableVenous Leg UlcersDrug: Bacteriophage|Drug: WPP-201 Bacteriophage|Drug: Bacteriophageshttps://ClinicalTrials.gov/show/NCT00663091
145085145085Group Cognitive Behavioral Therapy (CBT) Intervention for Women With Mild to Moderate DepressionCompletedNo Results AvailableDepression|AnxietyBehavioral: Brief CBT Group therapyhttps://ClinicalTrials.gov/show/NCT00663078
145086145086A Study of the Safety of PAZ-417 in Healthy Elderly AdultsTerminatedNo Results AvailableHealthyDrug: PAZ-417https://ClinicalTrials.gov/show/NCT00663065
145087145087Study Evaluating Etanercept for the Treatment of Moderate to Severe PsoriasisCompletedHas ResultsPlaque Psoriasis|PsoriasisDrug: Etanercept|Drug: Etanercepthttps://ClinicalTrials.gov/show/NCT00663052
145088145088Effects of Oxytocin Nasal Spray on Social AffiliationRecruitingNo Results AvailableSchizophreniaDrug: Oxytocin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00663039
145089145089Study Evaluating Bapineuzumab In Alzheimer Disease SubjectsCompletedHas ResultsAlzheimer DiseaseDrug: bapineuzumab|Drug: bapineuzumab|Drug: placebohttps://ClinicalTrials.gov/show/NCT00663026
145090145090Virtual Reality for Burn Wound Care Pain ControlRecruitingNo Results AvailablePain|AnxietyOther: Virtual Realityhttps://ClinicalTrials.gov/show/NCT00663013
145091145091Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin ResistanceCompletedNo Results AvailableAcromegaly|Diabetes|Insulin Resistance|Impaired Glucose Tolerancehttps://ClinicalTrials.gov/show/NCT00663000
145092145092Effect of Duration of Antibiotic Therapy on Recovery Following TonsillectomyCompletedNo Results AvailableTonsillectomyDrug: 7 days of amoxicillin|Drug: 3 days of amoxcillin followed by 4 days of placebohttps://ClinicalTrials.gov/show/NCT00662987
145093145093Searching for the Perfect Oil to Protect the Perineum: A Randomized-Controlled, Double-Blind TrialNot yet recruitingNo Results AvailableSecond Stage of LaborOther: perineal massage with Wheat Germ Oil during the second stage of labor|Other: perineal massage with almond oil during the second stage of laborhttps://ClinicalTrials.gov/show/NCT00662974
145094145094Forehead Lift FixationCompletedNo Results AvailableForeheadProcedure: Periosteum|Procedure: Bonehttps://ClinicalTrials.gov/show/NCT00662961
145095145095ZAR2007: R-CHOP in Folicular Lymphoma Patients no Treated Previously. Consolidation With 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®)SuspendedNo Results AvailableLymphomaDrug: Rituximab|Drug: Ibritumomab tiuxetanhttps://ClinicalTrials.gov/show/NCT00662948
145096145096Evaluation of Efficacity and Safety of Deep Brain Stimulation (DBS) in Chronic and Treatment-Resistant Cluster Headache(CH)CompletedNo Results AvailableCluster HeadacheProcedure: setting-up of an electrode in deep brainhttps://ClinicalTrials.gov/show/NCT00662935
145097145097Consequences of Hypoglycemia on Intensive Care Unit (ICU) PatientsCompletedNo Results AvailableCritical Illnesshttps://ClinicalTrials.gov/show/NCT00662922
145098145098Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive BladderCompletedHas ResultsUrinary Bladder, OveractiveDrug: Mirabegron|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00662909
145099145099To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential HypertensionCompletedNo Results AvailableOsteoarthritis|HypertensionDrug: naproxcinod 375 mg bid|Drug: naproxcinod 750 mg bid|Drug: naproxen 250 mg bid|Drug: naproxen 500 mg bid|Drug: ibuprofen 600 mg tidhttps://ClinicalTrials.gov/show/NCT00662896
145100145100Assessing the Effects of a Nasal Corticosteroid on PMI-150 (Intranasal Ketamine)CompletedNo Results AvailableHealthyDrug: PMI-150 (intranasal ketamine HCl); mometasone furoatehttps://ClinicalTrials.gov/show/NCT00662883
145101145101Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended VaccineCompletedNo Results AvailableDiphtheria|Tetanus|Whooping Cough|Polio|Haemophilus Influenzae Type bBiological: DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine)|Biological: Pentacel: DTaP-IPV/Hibhttps://ClinicalTrials.gov/show/NCT00662870
145102145102A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin LisproCompletedHas ResultsDiabetes Mellitus: Type 1Drug: Technosphere® Insulin Inhalation Powder|Drug: Technosphere Insulin® Inhalation Powder|Drug: RAA Populationhttps://ClinicalTrials.gov/show/NCT00662857
145103145103Vitamin D Supplementation in Younger WomenActive, not recruitingNo Results AvailableHypovitaminosis DDrug: vitamin D3https://ClinicalTrials.gov/show/NCT00662844
145104145104Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic PatientsCompletedHas ResultsDiabetic Foot UlcerDrug: Fragmin/ Dalteparin Sodium|Drug: Placebo for Fragmin/ Dalteparin Sodiumhttps://ClinicalTrials.gov/show/NCT00662831
145105145105Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034)CompletedHas ResultsMigraine Disorders|Heart Disease|Cerebrovascular Accident|TIA (Transient Ischemic Attack)|Vascular Diseases|Peripheral Vascular DiseasesDrug: Telcagepant|Drug: Acetaminophen/Paracetamol|Drug: Placebo to Telcagepant|Drug: Placebo to Acetaminophen/Paracetamolhttps://ClinicalTrials.gov/show/NCT00662818
145106145106Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Salmeterol/Fluticasone propionatehttps://ClinicalTrials.gov/show/NCT00662805
145107145107Efficacy and Safety Comparison of Tiotropium Daily + Salmeterol Daily or Twice Daily Versus Tiotropium Daily in Patients With COPDCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Tiotropium plus Salmeterol|Drug: Tiotropium|Drug: Salmeterolhttps://ClinicalTrials.gov/show/NCT00662792
145108145108Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB)TerminatedNo Results AvailableExercise-induced BronchospasmDrug: arformoterol|Drug: formoterol|Drug: placebohttps://ClinicalTrials.gov/show/NCT00662779
145109145109Intervention With Black Currant Seed Press Residues in Healthy SubjectsCompletedNo Results AvailableSmokingDietary Supplement: black currant seed press residue|Dietary Supplement: Bread without black currant seed press residues|Dietary Supplement: Baseline datahttps://ClinicalTrials.gov/show/NCT00662766
145110145110A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood PressureActive, not recruitingNo Results AvailableHypertensionDevice: Home monitoring|Other: monitor & phone callhttps://ClinicalTrials.gov/show/NCT00662753

* Görseller ve İçerik tekif hakkına sahip olabilir